Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial

NCT03980990 is registered in ClinicalTrials.gov with University of Saskatchewan as lead sponsor.

NCT NCT03980990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03980990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial
Lead sponsor
University of Saskatchewan
Phase
Phase 4
Overall status
Unknown status
Start date
June 17, 2019
Completion date
June 17, 2020
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, diabetes mellitus, metformin adverse reaction, unstable angina